Heidelberg Pharma AG (ETR:HPHA)
3.020
+0.090 (3.07%)
At close: Mar 27, 2026
Heidelberg Pharma AG Market Cap
Heidelberg Pharma AG has a market cap or net worth of €141.28 million as of March 27, 2026. Its market cap has increased by 16.59% in one year.
Market Cap
141.28M
Enterprise Value
126.41M
Revenue
6.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.02
Market Cap Chart
Since November 13, 2006, Heidelberg Pharma AG's market cap has decreased from 158.11M to 141.28M, a decrease of -10.65%. That is a compound annual growth rate of -0.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 141.28M | 21.77% |
| Dec 30, 2025 | 116.01M | 2.02% |
| Dec 30, 2024 | 113.72M | -34.75% |
| Dec 29, 2023 | 174.28M | -24.11% |
| Dec 30, 2022 | 229.66M | 41.34% |
| Dec 30, 2021 | 162.49M | -24.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 46.15B |
| Siemens Healthineers AG | 40.60B |
| Bayer Aktiengesellschaft | 37.60B |
| Fresenius SE & Co. KGaA | 24.82B |
| Medios AG | 299.44M |
| M1 Kliniken AG | 259.77M |
| Stratec SE | 233.39M |
| MEDICLIN Aktiengesellschaft | 171.95M |